Results 241 to 250 of about 48,421 (285)

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis. [PDF]

Circ Heart Fail
Zampieri M, Biagioni G, Del Franco A, Canepa M, Porto I, Zanoletti M, Labate ME, Porcari A, Bordignon L, Merlo M, Sinagra G, Tini G, Musumeci B, Barbato E, Autore C, Biagini E, Longhi S, Sena G, Ponziani A, Saturi G, Fico V, Argirò A, Mazzoni C, Fumagalli C, Olivotto I, Perfetto F, Cappelli F.   +26 more
europepmc   +1 more source

Data Sheet 2_Effect of catheter ablation with vein of Marshall ethanol infusion for perimitral flutter in a patient with senile transthyretin cardiac amyloidosis: a case report.pdf

Simon Fitouchi (16874904), Mickael Ohana (6793676), Thomas Cardi (16874907), Laurence Jesel (10314962), Halim Marzak (16874898)   +4 more
openalex   +1 more source

Invasive pressure-volume loop and PET-MR phenotyping in transthyretin cardiac amyloidosis: a multimodal imaging case report. [PDF]

Eur Heart J Case Rep
Venkateshvaran A, Pilebro B, Arvidsson S, Edbom F, Lindqvist P.   +4 more
europepmc   +1 more source

Quantitative Analysis of Endocardial and Epicardial Left Ventricular Myocardial Deformation in Patients with Cardiac Amyloidosis

, 2019
Kozuka, Ayako, Koyama, Jun, Sekijima, Yoshiki, Ikeda, Uichi   +3 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiac amyloidosis

Current Treatment Options in Cardiovascular Medicine, 1999
No definitive therapy is available for cardiac amyloidosis. Treatment with alkylating agents such as melphalan has improved survival. Patients who do not respond to melphalan have benefited from high-dose chemotherapy with cyclophosphamide followed by peripheral stem cell transplantation.
, Kashyap, , Hosenpud
openaire   +4 more sources

Cardiac amyloidosis

Expert Review of Cardiovascular Therapy, 2014
Amyloidosis is a condition characterized by the extracellular deposition of insoluble fibrillar protein in tissues and various organs including the heart. This review summarizes the clinical manifestations and diagnostic treatment approaches for cardiac amyloidosis.
Syed Wamique, Yusuf, Amirreza, Solhpour, Jose, Banchs, Juan C, Lopez-Mattei, Jean-Bernard, Durand, Cezar, Iliescu, Saamir A, Hassan, Muzaffar H, Qazilbash   +7 more
openaire   +2 more sources

Cardiac transthyretin amyloidosis

Heart, 2012
Cardiac amyloidosis of transthyretin fibril protein (ATTR) type is an infiltrative cardiomyopathy characterised by ventricular wall thickening and diastolic heart failure. Increased access to cardiovascular magnetic resonance imaging has led to a marked increase in referrals to our centre of Caucasian patients with wild-type ATTR (senile systemic ...
Jason N, Dungu, Lisa J, Anderson, Carol J, Whelan, Philip N, Hawkins   +3 more
openaire   +2 more sources

Primary cardiac amyloidosis

American Heart Journal, 1953
Abstract Two cases of amyloidosis limited to the heart and one case of amyloidosis involving the heart and lungs are reported. All three patients were men in, or close to, the ninth decade of life. In all three cases auricular fibrillation and congestive failure were present. The literature is reviewed and a distinction drawn between systemic primary
A I, THOMASHOW, W D, ANGLE, T G, MORRIONE   +2 more
openaire   +2 more sources